Significantly reduced HR activity was also reported when Survivin was silenced in breast cancer cells [38], or upon the indirect Survivin inhibitor YM155 and ionizing radiation in glioblastoma cells [39]. The gene discussed is BIRC5; the disease is breast cancer.